The National Institutes of Health (NIH) is offering Small Business Innovation Research (SBIR) Phase IIB Bridge Awards aimed at accelerating the development of cancer-relevant technologies toward commercialization. This funding opportunity is designed for small business concerns (SBCs) that have previously received SBIR or STTR Phase II awards and are seeking additional funding to advance their cancer-related projects. The initiative is particularly focused on bridging the funding gap often encountered after Phase II, promoting partnerships between awardees and third-party investors to facilitate the commercialization of innovative cancer therapies, diagnostics, and tools. The total funding available for fiscal year 2025 is $12 million, with applications due by August 21, 2024, and the project period may extend for up to three years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.